Literature DB >> 7761425

Involvement of the ALL-1 gene in a solid tumor.

R Baffa1, M Negrini, S A Schichman, K Huebner, C M Croce.   

Abstract

Translocations involving chromosome band 11q23, found in 5-10% of human acute leukemias, disrupt the ALL-1 gene. This gene is fused by reciprocal translocation with a variety of other genes in acute lymphoblastic and myelogenous leukemias, and it undergoes self-fusion in acute myeloid leukemias with normal karyotype or trisomy 11. Here we report an alteration of the ALL-1 gene in a gastric carcinoma cell line (Mgc80-3). Characterization of this rearrangement revealed a three-way complex translocation, involving chromosomes 1 and 11, resulting in a partial duplication of the ALL-1 gene. Sequencing of reverse transcription-PCR products and Northern blot analysis showed that only the partially duplicated ALL-1 gene was transcribed, producing an mRNA with exon 8 fused to exon 2. This report of ALL-1 gene rearrangement in a solid tumor suggests that ALL-1 plays a role in the pathogenesis of some solid malignancies. The absence of the normal transcript in this cell line, in association with the loss-of-heterozygosity studies on chromosome 11q23 seen in solid tumors, suggests that ALL-1 is involved in tumorigenesis by a loss-of-function mechanism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7761425      PMCID: PMC41819          DOI: 10.1073/pnas.92.11.4922

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias.

Authors:  S Ziemin-van der Poel; N R McCabe; H J Gill; R Espinosa; Y Patel; A Harden; P Rubinelli; S D Smith; M M LeBeau; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation.

Authors:  R Prasad; Y Gu; H Alder; T Nakamura; O Canaani; H Saito; K Huebner; R P Gale; P C Nowell; K Kuriyama
Journal:  Cancer Res       Date:  1993-12-01       Impact factor: 12.701

3.  Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs.

Authors:  T Nakamura; H Alder; Y Gu; R Prasad; O Canaani; N Kamada; R P Gale; B Lange; W M Crist; P C Nowell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

4.  Somatic mutations in the neurofibromatosis 1 gene in human tumors.

Authors:  Y Li; G Bollag; R Clark; J Stevens; L Conroy; D Fults; K Ward; E Friedman; W Samowitz; M Robertson
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

5.  Loss of heterozygosity in malignant melanoma at loci on chromosome 11 and 17 implicated in the pathogenesis of other cancers.

Authors:  I P Tomlinson; A J Gammack; J E Stickland; G J Mann; R M MacKie; R F Kefford; J O McGee
Journal:  Genes Chromosomes Cancer       Date:  1993-07       Impact factor: 5.006

6.  Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines.

Authors:  L B Andersen; J W Fountain; D H Gutmann; S A Tarlé; T W Glover; N C Dracopoli; D E Housman; F S Collins
Journal:  Nat Genet       Date:  1993-02       Impact factor: 38.330

7.  Analysis of the murine All-1 gene reveals conserved domains with human ALL-1 and identifies a motif shared with DNA methyltransferases.

Authors:  Q Ma; H Alder; K K Nelson; D Chatterjee; Y Gu; T Nakamura; E Canaani; C M Croce; L D Siracusa; A M Buchberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

8.  Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias.

Authors:  D C Tkachuk; S Kohler; M L Cleary
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

9.  Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.

Authors:  A Crozat; P Aman; N Mandahl; D Ron
Journal:  Nature       Date:  1993-06-17       Impact factor: 49.962

10.  Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23), and t(11;19)(q23;p13) chromosome translocations.

Authors:  G Cimino; D T Moir; O Canaani; K Williams; W M Crist; S Katzav; L Cannizzaro; B Lange; P C Nowell; C M Croce
Journal:  Cancer Res       Date:  1991-12-15       Impact factor: 12.701

View more
  5 in total

1.  The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy.

Authors:  Susan P Whitman; Shujun Liu; Tamara Vukosavljevic; Laura J Rush; Li Yu; Chunhui Liu; Marko I Klisovic; Kati Maharry; Martin Guimond; Matthew P Strout; Brian Becknell; Adrienne Dorrance; Rebecca B Klisovic; Christoph Plass; Clara D Bloomfield; Guido Marcucci; Michael A Caligiuri
Journal:  Blood       Date:  2005-03-17       Impact factor: 22.113

2.  Comparative genomic hybridization identifies loss of 18q22-qter as an early and specific event in tumorigenesis of midgut carcinoids.

Authors:  S Kytölä; A Höög; B Nord; B Cedermark; T Frisk; C Larsson; M Kjellman
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

3.  SET1, a yeast member of the trithorax family, functions in transcriptional silencing and diverse cellular processes.

Authors:  C Nislow; E Ray; L Pillus
Journal:  Mol Biol Cell       Date:  1997-12       Impact factor: 4.138

4.  The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene.

Authors:  Eric S Martin; Rossano Cesari; Francesca Pentimalli; Kristine Yoder; Richard Fishel; Andrew L Himelstein; S Eric Martin; Andrew K Godwin; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

5.  Antitumor efficacy of a recombinant adenovirus encoding endostatin combined with an E1B55KD-deficient adenovirus in gastric cancer cells.

Authors:  Li-xia Li; Yan-ling Zhang; Ling Zhou; Miao-la Ke; Jie-min Chen; Xiang Fu; Chun-ling Ye; Jiang-xue Wu; Ran-yi Liu; Wenlin Huang
Journal:  J Transl Med       Date:  2013-10-14       Impact factor: 5.531

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.